Equity Overview
Price & Market Data
Price: $52.30
Daily Change: -$0.05 / 0.10%
Daily Range: $52.30 - $52.69
Market Cap: $2,707,444,992
Daily Volume: 4,431
Performance Metrics
1 Week: 71.98%
1 Month: 31.93%
3 Months: 15.77%
6 Months: -11.59%
1 Year: -24.83%
YTD: 13.07%
Company Details
Employees: 182
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Soleno Therapeutics, Inc., biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is VYKAT XR, an extended-release tablets for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.